{"nct_id":"NCT05601882","title":"A Study to Evaluate Adverse Events and Change in Disease Activity Comparing Oral Upadacitinib to Subcutaneous Dupilumab in Adolescent and Adult Participants With Moderate to Severe Atopic Dermatitis","status":"COMPLETED","status_verified_date":"2025-01","start_date":"2022-11-28","start_date_type":"ACTUAL","primary_completion_date":"2024-03-19","primary_completion_date_type":"ACTUAL","completion_date":"2024-08-08","completion_date_type":"ACTUAL","phases":["PHASE3"],"tickers":["ABBV"]}